Nathaniel E. David, Director at KYTHERA BIOPHARMACEUTICALS INC (KYTH), sold 1,230 shares at $32.56 ($40K) on 2014-06-02, disclosed to the SEC on 2014-06-03.
Scheduled sale ($40k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| KYTH | SELL | 2015-03-10 | $340K | — | Filing → |
| KYTH | SELL | 2015-03-05 | $600K | — | Filing → |
| KYTH | SELL | 2015-03-03 | $76K | — | Filing → |